Avdulla Christos S, Tachirai Ntaniela
Department of Public Health, University of Patras, Patras, GRC.
Department of Public Health Policy, University of West Attica, Athens, GRC.
Cureus. 2024 Sep 9;16(9):e68999. doi: 10.7759/cureus.68999. eCollection 2024 Sep.
George N. Papanicolaou (1883-1962) is recognized as a pioneer in cytology and early cancer detection, whose groundbreaking work revolutionized women's healthcare. His development of the Pap smear, a simple yet powerful screening tool, dramatically improved the early diagnosis of cervical cancer, leading to a significant reduction in mortality rates and saving millions of lives worldwide. Born in Greece and extensively trained in medicine and biology, Papanicolaou conducted meticulous research at Cornell University, laying the foundation for modern preventive medicine. This historical vignette explores Papanicolaou's life, transformative achievements, and the innovative processes he championed. By examining his enduring contributions, we highlight his profound impact on public health and medical practice, which continues to inspire and guide healthcare professionals across generations.
乔治·N·帕帕尼科拉乌（1883 - 1962）被公认为细胞学和早期癌症检测领域的先驱，其开创性工作彻底改变了女性医疗保健状况。他发明的巴氏涂片检查法，是一种简单却强大的筛查工具，极大地改善了宫颈癌的早期诊断，导致全球死亡率大幅下降，拯救了数百万人的生命。帕帕尼科拉乌出生于希腊，在医学和生物学方面接受了广泛的培训，他在康奈尔大学进行了细致入微的研究，为现代预防医学奠定了基础。这篇历史小传探讨了帕帕尼科拉乌的生平、变革性成就以及他所倡导的创新方法。通过审视他的持久贡献，我们突出了他对公共卫生和医疗实践的深远影响，这种影响继续激励和指引着一代又一代的医疗保健专业人员。
